HL7.FHIR.UV.SHC-VACCINATION\Vaccine: CVX

This page is part of the SMART Health Cards Vaccination and Testing, Release 1 | STU 1 (v0.6.2: STU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. No current official version has been published yet. For a full list of available versions, see the Directory of published versions

ValueSet: Vaccine: CVX

Summary

Defining URL:

http://hl7.org/fhir/uv/shc-vaccination/ValueSet/vaccine-cvx

Version:

0.6.2

Name:

VaccineCVX

Title:

Vaccine: CVX

Status:

Active as of 2021-08-13T13:26:56+00:00

Definition:

This value set includes all CVX codes, which identify vaccine products.

Publisher:

HL7 International - Public Health Work Group

Source Resource:

XML / JSON / Turtle

References

Logical Definition (CLD)

Include all codes defined in http://hl7.org/fhir/sid/cvx

Expansion

This value set contains 214 concepts

Expansion based on http://hl7.org/fhir/sid/cvx version 20210406

All codes from system http://hl7.org/fhir/sid/cvx

Code	Display	Definition
54	adenovirus vaccine, type 4, live, oral	adenovirus, type 4
55	adenovirus vaccine, type 7, live, oral	adenovirus, type 7
82	adenovirus vaccine, unspecified formulation	adenovirus, NOS1
24	anthrax vaccine	anthrax
19	Bacillus Calmette-Guerin vaccine	BCG
27	botulinum antitoxin	botulinum antitoxin
26	cholera vaccine, unspecified formulation	cholera
29	cytomegalovirus immune globulin, intravenous	CMVIG
56	dengue fever vaccine	dengue fever
12	diphtheria antitoxin	diphtheria antitoxin
28	diphtheria and tetanus toxoids, adsorbed for pediatric use	DT (pediatric)
20	diphtheria, tetanus toxoids and acellular pertussis vaccine	DTaP
106	diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens	DTaP, 5 pertussis antigens6
107	diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation	DTaP, NOS
110	DTaP-hepatitis B and poliovirus vaccine	DTaP-Hep B-IPV
50	DTaP-Haemophilus influenzae type b conjugate vaccine	DTaP-Hib
120	diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)	DTaP-Hib-IPV
130	Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated
01	diphtheria, tetanus toxoids and pertussis vaccine	DTP
22	DTP-Haemophilus influenzae type b conjugate vaccine	DTP-Hib
102	DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine	DTP-Hib-Hep B
57	hantavirus vaccine	hantavirus
52	hepatitis A vaccine, adult dosage	Hep A, adult
83	hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule	Hep A, ped/adol, 2 dose
84	hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule	Hep A, ped/adol, 3 dose
31	hepatitis A vaccine, pediatric dosage, unspecified formulation	Hep A, pediatric, NOS
85	hepatitis A vaccine, unspecified formulation	Hep A, NOS
104	hepatitis A and hepatitis B vaccine	Hep A-Hep B
30	hepatitis B immune globulin	HBIG
08	hepatitis B vaccine, pediatric or pediatric/adolescent dosage	Hep B, adolescent or pediatric
42	hepatitis B vaccine, adolescent/high risk infant dosage	Hep B, adolescent/high risk infant2
43	hepatitis B vaccine, adult dosage	Hep B, adult4
44	hepatitis B vaccine, dialysis patient dosage	Hep B, dialysis
45	hepatitis B vaccine, unspecified formulation	Hep B, NOS
58	hepatitis C vaccine	Hep C
59	hepatitis E vaccine	Hep E
60	herpes simplex virus, type 2 vaccine	herpes simplex 2
46	Haemophilus influenzae type b vaccine, PRP-D conjugate	Hib (PRP-D)
47	Haemophilus influenzae type b vaccine, HbOC conjugate	Hib (HbOC)
48	Haemophilus influenzae type b vaccine, PRP-T conjugate	Hib (PRP-T)
49	Haemophilus influenzae type b vaccine, PRP-OMP conjugate	Hib (PRP-OMP)
17	Haemophilus influenzae type b vaccine, conjugate unspecified formulation	Hib, NOS
51	Haemophilus influenzae type b conjugate and Hepatitis B vaccine	Hib-Hep B
61	human immunodeficiency virus vaccine	HIV
118	human papilloma virus vaccine, bivalent	HPV, bivalent
62	human papilloma virus vaccine, quadrivalent	HPV, quadrivalent
86	immune globulin, intramuscular	IG
87	immune globulin, intravenous	IGIV
14	immune globulin, unspecified formulation	IG, NOS
111	influenza virus vaccine, live, attenuated, for intranasal use	influenza, live, intranasal
15	influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE	influenza, split (incl. purified surface antigen)
16	influenza virus vaccine, whole virus	influenza, whole
88	influenza virus vaccine, unspecified formulation	influenza, NOS
123	influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)
10	poliovirus vaccine, inactivated	IPV
02	trivalent poliovirus vaccine, live, oral	OPV
89	poliovirus vaccine, unspecified formulation	polio, NOS
39	Japanese Encephalitis Vaccine SC	Japanese encephalitis
63	Junin virus vaccine	Junin virus
64	leishmaniasis vaccine	leishmaniasis
65	leprosy vaccine	leprosy
66	Lyme disease vaccine	Lyme disease
03	measles, mumps and rubella virus vaccine	MMR
04	measles and rubella virus vaccine	M/R
94	measles, mumps, rubella, and varicella virus vaccine	MMRV
67	malaria vaccine	malaria
05	measles virus vaccine	measles
68	melanoma vaccine	melanoma
32	meningococcal polysaccharide vaccine (MPSV4)	meningococcal
103	meningococcal C conjugate vaccine	meningococcal C conjugate
114	meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)	meningococcal A,C,Y,W-135 diphtheria conjugate
108	meningococcal ACWY vaccine, unspecified formulation	meningococcal, NOS
07	mumps virus vaccine	mumps
69	parainfluenza-3 virus vaccine	parainfluenza-3
11	pertussis vaccine	pertussis
23	plague vaccine	plague
33	pneumococcal polysaccharide vaccine, 23 valent	pneumococcal
100	pneumococcal conjugate vaccine, 7 valent	pneumococcal conjugate
109	pneumococcal vaccine, unspecified formulation	pneumococcal, NOS
70	Q fever vaccine	Q fever
18	rabies vaccine, for intramuscular injection RETIRED CODE	rabies, intramuscular injection
40	rabies vaccine, for intradermal injection	rabies, intradermal injection
90	rabies vaccine, unspecified formulation	rabies, NOS
72	rheumatic fever vaccine	rheumatic fever
73	Rift Valley fever vaccine	Rift Valley fever
34	rabies immune globulin	RIG
119	rotavirus, live, monovalent vaccine	rotavirus, monovalent
122	rotavirus vaccine, unspecified formulation	rotavirus, NOS1
116	rotavirus, live, pentavalent vaccine	rotavirus, pentavalent
74	rotavirus, live, tetravalent vaccine	rotavirus, tetravalent
71	respiratory syncytial virus immune globulin, intravenous	RSV-IGIV
93	respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular	RSV-MAb
06	rubella virus vaccine	rubella
38	rubella and mumps virus vaccine	rubella/mumps
76	Staphylococcus bacteriophage lysate	Staphylococcus bacterio lysate
113	tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)	Td (adult)
09	tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)	Td (adult)
115	tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed	Tdap
35	tetanus toxoid, adsorbed	tetanus toxoid
112	tetanus toxoid, unspecified formulation	tetanus toxoid, NOS
77	tick-borne encephalitis vaccine	tick-borne encephalitis
13	tetanus immune globulin	TIG
95	tuberculin skin test; old tuberculin, multipuncture device	TST-OT tine test
96	tuberculin skin test; purified protein derivative solution, intradermal	TST-PPD intradermal
97	tuberculin skin test; purified protein derivative, multipuncture device	TST-PPD tine test
98	tuberculin skin test; unspecified formulation	TST, NOS
78	tularemia vaccine	tularemia vaccine
91	typhoid vaccine, unspecified formulation	typhoid, NOS
25	typhoid vaccine, live, oral	typhoid, oral
41	typhoid vaccine, parenteral, other than acetone-killed, dried	typhoid, parenteral
53	typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)	typhoid, parenteral, AKD (U.S. military)
101	typhoid Vi capsular polysaccharide vaccine	typhoid, ViCPs
75	vaccinia (smallpox) vaccine	vaccinia (smallpox)
105	vaccinia (smallpox) vaccine, diluted	vaccinia (smallpox) diluted
79	vaccinia immune globulin	vaccinia immune globulin
21	varicella virus vaccine	varicella
81	Venezuelan equine encephalitis, inactivated	VEE, inactivated
80	Venezuelan equine encephalitis, live, attenuated	VEE, live
92	Venezuelan equine encephalitis vaccine, unspecified formulation	VEE, NOS
36	varicella zoster immune globulin	VZIG
117	varicella zoster immune globulin (Investigational New Drug)	VZIG (IND)
37	yellow fever vaccine	yellow fever
121	zoster vaccine, live	zoster
998	no vaccine administered	no vaccine administered5
999	unknown vaccine or immune globulin	unknown
99	RESERVED - do not use	RESERVED - do not use3
133	pneumococcal conjugate vaccine, 13 valent
134	Japanese Encephalitis vaccine for intramuscular administration
137	HPV, unspecified formulation
136	meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)
135	influenza, high dose seasonal, preservative-free
131	Historical record of a typhus vaccination
132	Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine.
128	Novel influenza-H1N1-09, all formulations
125	Novel Influenza-H1N1-09, live virus for nasal administration
126	Novel influenza-H1N1-09, preservative-free, injectable
127	Novel influenza-H1N1-09, injectable
138	tetanus and diphtheria toxoids, not adsorbed, for adult use
139	Td(adult) unspecified formulation
140	Influenza, seasonal, injectable, preservative free
129	Japanese Encephalitis vaccine, unspecified formulation
141	Influenza, seasonal, injectable
142	tetanus toxoid, not adsorbed
143	Adenovirus, type 4 and type 7, live, oral
144	seasonal influenza, intradermal, preservative free
145	respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular
146	Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine.
147	Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)
148	Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine
149	influenza, live, intranasal, quadrivalent
150	Influenza, injectable, quadrivalent, preservative free
151	influenza nasal, unspecified formulation
152	Pneumococcal Conjugate, unspecified formulation
153	Influenza, injectable, Madin Darby Canine Kidney, preservative free
154	Hepatitis A immune globulin
155	Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free
156	Rho(D) Immune globulin- IV or IM
157	Rho(D) Immune globulin - IM
158	influenza, injectable, quadrivalent, contains preservative
159	Rho(D) Unspecified formulation
160	Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013
801	AS03 Adjuvant
161	Influenza, injectable,quadrivalent, preservative free, pediatric
162	meningococcal B vaccine, fully recombinant
163	meningococcal B vaccine, recombinant, OMV, adjuvanted
164	meningococcal B, unspecified formulation
165	Human Papillomavirus 9-valent vaccine
166	influenza, intradermal, quadrivalent, preservative free, injectable
167	meningococcal vaccine of unknown formulation and unknown serogroups
168	Seasonal trivalent influenza vaccine, adjuvanted, preservative free
169	Hep A, live attenuated-IM
170	non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
171	Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent
172	cholera, WC-rBS
173	cholera, BivWC
174	cholera, live attenuated
175	Human Rabies vaccine from human diploid cell culture
176	Human rabies vaccine from Chicken fibroblast culture
177	pneumococcal conjugate vaccine, 10 valent
178	Non-US bivalent oral polio vaccine (types 1 and 3)
179	Non-US monovalent oral polio vaccine, unspecified formulation
180	tetanus immune globulin
181	anthrax immune globulin
182	Oral Polio Vaccine, Unspecified formulation
183	Yellow fever vaccine alternative formulation
184	Yellow fever vaccine, unspecified formulation
185	Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free
186	Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative
187	zoster vaccine recombinant
188	zoster vaccine, unspecified formulation
189	Hepatitis B vaccine (recombinant), CpG adjuvanted
190	Typhoid conjugate vaccine (non-US)
191	meningococcal A polysaccharide vaccine (non-US)
192	meningococcal AC polysaccharide vaccine (non-US)
193	hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)
194	influenza, Southern Hemisphere, unspecified formulation
195	Diphtheria, Tetanus, Poliomyelitis adsorbed
196	tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified
197	influenza, high-dose seasonal, quadrivalent, .7mL dose, preservative free
200	influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free
201	influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative
202	influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative
198	Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)
203	meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine .5mL dose, preservative free
205	influenza, seasonal vaccine, quadrivalent, adjuvanted, .5mL dose, preservative free
206	smallpox monkeypox vaccine, live attenuated, preservative free (National Stockpile)
207	SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose
208	SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose
213	SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
210	SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL
212	SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 ml
204	Ebola Zaire vaccine, live, recombinant, 1mL dose
214	Ebola, unspecified
211	SARS-COV-2 (COVID-19) vaccine, Subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL per dose

Explanation of the columns that may appear on this page:

Level

A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies

Source

The source of the definition of the code (when the value set draws in codes defined elsewhere)

Code

The code (used as the code in the resource instance)

Display

The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application

Definition

An explanation of the meaning of the concept

Comments

Additional notes about how to use the code